For quotations, please use our online quotation form, and you may also contact us by
The Neo Rabbit-mAb™ developed 3.0 generation of recombinant Rabbit Monoclonal Antibody is exclusively available from NEO Scientific. Rabbit-mAb™ employs innovative cell sorting, enriching, bioinformatics, and recombinant monoclonal antibody technologies. NEO Scientific selects the desired antibody directly from B cells.
Our technologies provide more candidates that are unreachable by traditional technologies - our in-house bioinformatics optimizes the selection, our new generation of gene synthesis solutions cuts down the cost of antibody engineering, and our XPromoter 2.0 can highly express recombinant antibodies.
NEO provides antibodies with high specificity and sensitivity in multiple applications and manufactures cost-efficient large-scale antibodies.
Phase II: Cell Sorting, Screening, Sequencing
Phase III: Cloning, Expression, and Characterization
We also provide comprehensive services for antibody cloning, engineering, expression, and purification in addition to custom antibody development.
|Project Phases||Time frame|
|I. Immunization ||60-80 Days|
|II. Screening and Selection ||30-40 Days|
|III. Cloning & Expression ||25-35 Days|
2-3mg of four different recombinant rabbit monoclonal antibodies
(guarantee indirect ELISA)
The rabbit immune system generates antibody diversity and optimizes affinity via different mechanisms than rodents. Neo Ra-mAb 3.0 develops antiobodies that not only recognize antigens efficiently, but also with specificity and consistency. On average, our antibodies have 10-100x higher affinity than mouse monoclonals. Immunization of rabbits results in a highly diverse suite of B-lymphocytes and an abundance of splenocytes. The breadth of available cells provides greater opportunities to screen antibodies that distinguish between similar molecules and improve specificity accordingly.